Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Neogenomics Company Profile (NYSE:NEO)

Consensus Ratings for Neogenomics (NYSE:NEO) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $6.50 (88.41% upside)

Analysts' Ratings History for Neogenomics (NYSE:NEO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/14/2014StephensInitiated CoverageOverweight$6.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/23/2013ZacksReiterated RatingOutperform -> Outperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Ladenburg ThalmannDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/14/2013Ladenburg ThalmannBoost Price TargetBuy$3.50 -> $3.75ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)